Extending GenVoy-ILM product line to accelerate mRNA and saRNA vaccine development GMP-compatible lipids ensure scalability for large-scale manufacturing Cytiva introduces its latest innovation, the RNA delivery LNP kit, specifically designed… Read More
Milestone marks a significant step toward producing mRNA vaccines in Canada by 2025 CAMBRIDGE, MA – Moderna, Inc. (Nasdaq:MRNA) announced that its manufacturing facility in Laval, Quebec, has been granted… Read More
Almost half (46%) of older Canadians surveyed had never heard of RSV, despite a large majority (65%) reporting having had a respiratory illness in the previous 12 months[1] With approximately… Read More
VANCOUVER, BC – DIGITAL, Canada’s Global Innovation Cluster for digital technologies, celebrates the impacts delivered through its $500+ million investments in Canadian-led, AI-enabled innovations. Through these investments, Canadian organizations are solving some… Read More
Full data from the primary analysis of the positive, single-arm Phase 2 PICCOLO trial, evaluating mirvetuximab soravtansine (ELAHERE®), for high folate receptor-alpha (FRα) expressing platinum-sensitive ovarian cancer (PSOC) (mini-oral presentation)…. Read More
